semaglutide pdufa Exciting Phase 3 Data from Novo Nordisk for Patients with MASH Semaglutide - Research Peptide -

FDA announced it is hosting a two-day hybrid workshop in partnership with the University of Maryland Center of Excellence in Regulatory Science and Innovation to discuss developing antihypertensive therapies for pediatric patients

Llonch, S

In June 2025, the country allowed all doctors, rather than just specialists such as endocrinologists, to prescribe such drugs

10.1007/s00430-021-00727-0 Med Microbiol Immunol

The development of novel dual- or triple-receptor agonists that bind to the receptors not only for GLP-1 but also to the receptors for glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon is intended to address different metabolic pathways for carbohydrate, lipid, and protein metabolism simultaneously